Antonio
Fontanellas Roma
Profesional Investigador
Centro Nacional de Biotecnología
Madrid, EspañaCentro Nacional de Biotecnología -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
-
Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria
Science Translational Medicine, Vol. 14, Núm. 627
2018
-
Bioengineered PBGD variant improves the therapeutic index of gene therapy vectors for acute intermittent porphyria
Human Molecular Genetics, Vol. 27, Núm. 21, pp. 3688-3696